Aletta: The Robot That Can Now Draw Blood Without Human Hands
One of medicine’s most routine procedures is entering a new era of automation. The U.S. Food and Drug Administration (FDA) authorized Aletta on August 19, 2026, the first autonomous, stand-alone robotic device capable of drawing blood from a person’s arm without an operator directly manipulating the needle during the procedure. The decision creates a new […]
The U.S. Food and Drug Administration (FDA) has granted Aletta, a robotic device, marketing authorization on August 19, 2026, making it the first autonomous, stand-alone blood draw system capable of performing the procedure without a human directly manipulating the needle. The FDA approved the device through the De Novo pathway, which is utilized for novel low- to moderate-risk devices lacking an existing legally marketed equivalent.
Vitestro, a Dutch medical technology company, developed Aletta, which combines robotics, ultrasound, and near-infrared imaging to identify and draw blood from a patient's arm. The FDA emphasized that Aletta operates under professional supervision, with one person authorized to oversee up to three devices simultaneously and remain available in case of issues.
The system is designed to help address staffing shortages in blood collection services while maintaining the highest standards of safety and effectiveness.
Written by urgent.news from Colombia One's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
